News
Hudson Technologies sees volatility amid earnings decline and refrigerant price shifts. Find out how HDSN managed to surge 20 ...
The average of price targets set by Wall Street analysts indicates a potential upside of 108.8% in Nuvectis Pharma (NVCT). While the effectiveness of this highly sought-after metric is questionable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback